Authors:
MacKenzie, IZ
Bowell, P
Gregory, H
Pratt, G
Guest, C
Entwistle, CC
Citation: Iz. Mackenzie et al., Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study, BR J OBST G, 106(5), 1999, pp. 492-497
Authors:
Seibel, NL
Blaney, SM
O'Brien, M
Krailo, M
Hutchinson, R
Mosher, RB
Balis, FM
Gregory, H
Citation: Nl. Seibel et al., Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: A collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial, CLIN CANC R, 5(4), 1999, pp. 733-737
Authors:
Hodgson, S
Milner, B
Brown, I
Bevilacqua, G
Chang-Claude, J
Eccles, D
Evans, G
Gregory, H
Moller, P
Morrison, P
Steel, M
Stoppa-Lyonnet, D
Vasen, H
Haites, N
Citation: S. Hodgson et al., Cancer genetics services in Europe, DIS MARKER, 15(1-3), 1999, pp. 3-13
Authors:
Miedzybrodzka, Z
Hamilton, NM
Gregory, H
Milner, B
Frade, I
Sinclair, T
Mollison, J
Haites, N
Citation: Z. Miedzybrodzka et al., Teaching breast cancer genetics to medical students: Evaluation of a computer assister learning (CAL) package, DIS MARKER, 15(1-3), 1999, pp. 157-157
Authors:
Moller, P
Reis, MM
Evans, G
Vasen, H
Haites, N
Anderson, E
Steel, CM
Apold, J
Lalloo, F
Maehle, L
Preece, P
Gregory, H
Heimdal, K
Citation: P. Moller et al., Efficacy of early diagnosis and treatment in women with a family history of breast cancer, DIS MARKER, 15(1-3), 1999, pp. 179-186
Citation: H. Gregory et al., Audit of women attending the Aberdeen Genetic Clinic with a family historyof breast cancer who subsequently develop cancer, DIS MARKER, 15(1-3), 1999, pp. 201-203
Authors:
Moller, P
Evans, G
Haites, N
Vasen, H
Reis, MM
Anderson, E
Apold, J
Hodgson, S
Eccles, D
Olsson, H
Stoppa-Lyonnet, D
Chang-Claude, J
Morrison, PJ
Bevilacqua, G
Heimdal, K
Maehle, L
Lalloo, F
Gregory, H
Preece, P
Borg, A
Nevin, NC
Caligo, M
Steel, CM
Citation: P. Moller et al., Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer, DIS MARKER, 15(1-3), 1999, pp. 207-211